Literature DB >> 1711170

Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system.

R S Ahima1, R E Harlan.   

Abstract

The rat brain and spinal cord have been mapped for Type II glucocorticoid receptor-like immunoreactivity in neurons and glia, using a monoclonal antibody, BUGR2, which recognizes an epitope close to the DNA-binding domain of the rat Type II receptor. The study revealed a widespread distribution of Type II-like immunoreactive neurons and glia, and a heterogeneity of densities and intensities of immunoreactive elements. Our results corresponded to a large extent with previous immunocytochemical mapping using Ig2a, a monoclonal antibody against a different epitope in the variable domain, with some notable differences in the hippocampus, hypothalamus and cerebellum. There was also a good correlation between immunocytochemical mapping and binding studies, [3H]steroid autoradiography and mRNA localization of the Type II receptor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1711170     DOI: 10.1016/0306-4522(90)90244-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  99 in total

1.  Non-linear changes of electrocortical activity after antenatal betamethasone treatment in fetal sheep.

Authors:  M Schwab; K Schmidt; M Roedel; T Mueller; H Schubert; M A Anwar; P W Nathaniels
Journal:  J Physiol       Date:  2001-03-01       Impact factor: 5.182

2.  Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice.

Authors:  N P Bowles; M N Hill; S M Bhagat; I N Karatsoreos; C J Hillard; B S McEwen
Journal:  Neuroscience       Date:  2011-09-10       Impact factor: 3.590

3.  Olfactory-hypoglossal connections.

Authors:  Ombretta Mameli; Antonella Russo; Rosemary Borke; Francesco Melis; Marcello Alessandro Caria; Rosaria Pellitteri; Claudio Tavera; Stefania Stanzani
Journal:  Pflugers Arch       Date:  2003-01-18       Impact factor: 3.657

Review 4.  Stress, depression and Parkinson's disease.

Authors:  Ann M Hemmerle; James P Herman; Kim B Seroogy
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

Review 5.  60 YEARS OF NEUROENDOCRINOLOGY: Redefining neuroendocrinology: stress, sex and cognitive and emotional regulation.

Authors:  Bruce S McEwen; Jason D Gray; Carla Nasca
Journal:  J Endocrinol       Date:  2015-05-01       Impact factor: 4.286

6.  Role of glucocorticoids in tuning hindbrain stress integration.

Authors:  Rong Zhang; Ryan Jankord; Jonathan N Flak; Matia B Solomon; David A D'Alessio; James P Herman
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

Review 7.  Chronic stress- and sex-specific neuromorphological and functional changes in limbic structures.

Authors:  Katie J McLaughlin; Sarah E Baran; Cheryl D Conrad
Journal:  Mol Neurobiol       Date:  2009-07-31       Impact factor: 5.590

Review 8.  Genomic and epigenomic mechanisms of glucocorticoids in the brain.

Authors:  Jason D Gray; Joshua F Kogan; Jordan Marrocco; Bruce S McEwen
Journal:  Nat Rev Endocrinol       Date:  2017-09-01       Impact factor: 43.330

9.  Consequence of long-term exposure to corticosterone or dexamethasone on ethanol consumption in the adrenalectomized rat, and the effect of type I and type II corticosteroid receptor antagonists.

Authors:  C Fahlke; E Hård; C J Eriksson; J A Engel; S Hansen
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

10.  Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory.

Authors:  Hila Abush; Irit Akirav
Journal:  Neuropsychopharmacology       Date:  2013-02-20       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.